Literature DB >> 2704071

Detection of virus-specific RNA-dependent RNA polymerase activity in extracts from cells infected with lymphocytic choriomeningitis virus: in vitro synthesis of full-length viral RNA species.

F V Fuller-Pace1, P J Southern.   

Abstract

We have developed an in vitro assay for the lymphocytic choriomeningitis virus (LCMV) RNA-dependent RNA polymerase with ribonucleoprotein complexes extracted from acutely infected tissue culture cells. The RNA products synthesized in vitro corresponded in size to the full-length genomic L and S RNAs and subgenomic NP and GP mRNAs normally produced in vivo during acute LCMV infection. In a temporal analysis spanning the first 72 h of acute infection, the in vitro polymerase activity of ribonucleoprotein complexes was maximal at 16 h and declined significantly at later times. In contrast, the intracellular levels of the viral L protein (the putative polymerase protein) appeared to be maximal at 48 to 72 h postinfection. Our results suggest that the accumulation of L protein correlates with reduced viral replication and transcription at later times in acute infection and may be involved in the transition from acute to persistent LCMV infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2704071      PMCID: PMC250606          DOI: 10.1128/JVI.63.5.1938-1944.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Lymphocytic choriomeningitis virus. IX. Properties of the nucleocapsid.

Authors:  M Bruns; W Zeller; H Rohdewohld; F Lehmann-Grube
Journal:  Virology       Date:  1986-05       Impact factor: 3.616

4.  Preparative and analytical purification of DNA from agarose.

Authors:  B Vogelstein; D Gillespie
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

5.  Protein structure of lymphocytic choriomeningitis virus: identification of the virus structural and cell associated polypeptides.

Authors:  M J Buchmeier; J H Elder; M B Oldstone
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

6.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

7.  Lymphocytic choriomeningitis virus RNAs.

Authors:  I R Pedersen
Journal:  Nat New Biol       Date:  1971-11-24

8.  Tubulin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs.

Authors:  S A Moyer; S C Baker; J L Lessard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

9.  Virion RNA species of the arenaviruses Pichinde, Tacaribe, and Tamiami.

Authors:  A C Vezza; J P Clewley; G P Gard; N Z Abraham; R W Compans; D H Bishop
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

10.  Genetic mapping of lymphocytic choriomeningitis virus pathogenicity: virulence in guinea pigs is associated with the L RNA segment.

Authors:  Y Riviere; R Ahmed; P J Southern; M J Buchmeier; M B Oldstone
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

View more
  21 in total

1.  NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs.

Authors:  K J Lee; I S Novella; M N Teng; M B Oldstone; J C de La Torre
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome.

Authors:  T I Cornu; J C de la Torre
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles.

Authors:  Ki Jeong Lee; Mar Perez; Daniel D Pinschewer; Juan Carlos de la Torre
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  Characterization of the arenavirus RING finger Z protein regions required for Z-mediated inhibition of viral RNA synthesis.

Authors:  Tatjana I Cornu; Juan Carlos de la Torre
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

5.  Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Mar Perez; Juan Carlos de la Torre
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Domain structure of Lassa virus L protein.

Authors:  Linda Brunotte; Michaela Lelke; Meike Hass; Katja Kleinsteuber; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

7.  Replicon system for Lassa virus.

Authors:  Meike Hass; Uta Gölnitz; Stefanie Müller; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  An N-terminal region of Lassa virus L protein plays a critical role in transcription but not replication of the virus genome.

Authors:  Michaela Lelke; Linda Brunotte; Carola Busch; Stephan Günther
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  Mutational evidence for a structural model of the Lassa virus RNA polymerase domain and identification of two residues, Gly1394 and Asp1395, that are critical for transcription but not replication of the genome.

Authors:  Meike Hass; Michaela Lelke; Carola Busch; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

Review 10.  Structure-function relationship of the mammarenavirus envelope glycoprotein.

Authors:  Wei Wang; Zheng Zhou; Leike Zhang; Shaobo Wang; Gengfu Xiao
Journal:  Virol Sin       Date:  2016-08-04       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.